Page last updated: 2024-10-20
phosphorylethanolamine and Acute Promyelocytic Leukemia
phosphorylethanolamine has been researched along with Acute Promyelocytic Leukemia in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ferreira, AK | 1 |
| Santana-Lemos, BA | 1 |
| Rego, EM | 1 |
| Filho, OM | 1 |
| Chierice, GO | 1 |
| Maria, DA | 1 |
Other Studies
1 other study available for phosphorylethanolamine and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Drug Evaluation, Preclinical; Ethanolamines; Hum | 2013 |